These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 21781682)
1. Inhibition by arsenite of anticancer drug cis-diamminedichloroplatinum(II) induced DNA repair and drug resistance in HeLa cells. Chao CC Environ Toxicol Pharmacol; 1996 May; 1(3):199-205. PubMed ID: 21781682 [TBL] [Abstract][Full Text] [Related]
2. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair. Chao CC Mol Pharmacol; 1994 Jun; 45(6):1137-44. PubMed ID: 8022407 [TBL] [Abstract][Full Text] [Related]
3. Enhanced excision repair of DNA damage due to cis-diamminedichloroplatinum(II) in resistant cervix carcinoma HeLa cells. Chao CC Eur J Pharmacol; 1994 Aug; 268(3):347-55. PubMed ID: 7805758 [TBL] [Abstract][Full Text] [Related]
4. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair. Chao CC Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556 [TBL] [Abstract][Full Text] [Related]
5. Use of a monoclonal antibody to detect DNA damage caused by the anticancer drug cis-diamminedichloroplatinum (II) in vivo and in vitro. Chao CC; Shieh TC; Huang H FEBS Lett; 1994 Oct; 354(1):103-9. PubMed ID: 7957889 [TBL] [Abstract][Full Text] [Related]
6. Enhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to cis-diamminedichloroplatinum(II). Chao CC; Lee YL; Cheng PW; Lin-Chao S Cancer Res; 1991 Jan; 51(2):601-5. PubMed ID: 1898714 [TBL] [Abstract][Full Text] [Related]
7. DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA. Sheibani N; Jennerwein MM; Eastman A Biochemistry; 1989 Apr; 28(7):3120-4. PubMed ID: 2742829 [TBL] [Abstract][Full Text] [Related]
8. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973 [TBL] [Abstract][Full Text] [Related]
9. In vitro studies on the mechanisms of oxaliplatin resistance. Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458 [TBL] [Abstract][Full Text] [Related]
10. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W; Chaney SG Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of excision repair of cisplatin-DNA adducts by cell-free extract from a cisplatin-resistant rat cell line. Hibino Y; Hiraoka Y; Kamiuchi S; Kusashio E; Sugano N Biochem Pharmacol; 1999 Jun; 57(12):1415-22. PubMed ID: 10353263 [TBL] [Abstract][Full Text] [Related]
12. The formation and repair of cisplatin-DNA adducts in wild-type and cisplatin-resistant L1210 cells: comparison of immunocytochemical determination with detection in isolated DNA. Blommaert FA; Floot BG; van Dijk-Knijnenburg HC; Berends F; Baan RA; Schornagel JH; den Engelse L; Fichtinger-Schepman AM Chem Biol Interact; 1998 Jan; 108(3):209-25. PubMed ID: 9528691 [TBL] [Abstract][Full Text] [Related]
13. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation. Hill BT; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Bedford P Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):75-83. PubMed ID: 2380098 [TBL] [Abstract][Full Text] [Related]
14. Apparent alterations in the early stage of excision repair of UV-induced DNA damages in a HeLa mutant cell line that is resistant to genotoxic stresses. Chao CC; Huang SL Mutat Res; 1993 Sep; 303(1):19-27. PubMed ID: 7690902 [TBL] [Abstract][Full Text] [Related]
15. Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro. Oldenburg J; Begg AC; van Vugt MJ; Ruevekamp M; Schornagel JH; Pinedo HM; Los G Cancer Res; 1994 Jan; 54(2):487-93. PubMed ID: 8275486 [TBL] [Abstract][Full Text] [Related]
16. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines. Aida T; Bodell WJ Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016 [TBL] [Abstract][Full Text] [Related]
17. Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells. Chiang HC; Tsou TC Toxicol In Vitro; 2009 Aug; 23(5):897-905. PubMed ID: 19470404 [TBL] [Abstract][Full Text] [Related]
18. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Masuda H; Ozols RF; Lai GM; Fojo A; Rothenberg M; Hamilton TC Cancer Res; 1988 Oct; 48(20):5713-6. PubMed ID: 3139281 [TBL] [Abstract][Full Text] [Related]
19. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines. Delmastro DA; Li J; Vaisman A; Solle M; Chaney SG Cancer Chemother Pharmacol; 1997; 39(3):245-53. PubMed ID: 8996528 [TBL] [Abstract][Full Text] [Related]
20. Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells. Johnson SW; Swiggard PA; Handel LM; Brennan JM; Godwin AK; Ozols RF; Hamilton TC Cancer Res; 1994 Nov; 54(22):5911-6. PubMed ID: 7954422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]